LRMR Larimar Therapeutics Q4 loss widens 41 miss as drug development costs climb shares edge lower Corteva CTVA Stock Price Target Corteva Inc posts 21 EPS miss revenue at 174B Frontier FNUC Stock Estimate Revisions Recovers 20260418